Bibliography
- Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012;379:943-52
- Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-21
- de Vries RB, Oerlemans A, Trommelmans L, et al. Ethical aspects of tissue engineering: a review. Tissue Eng Part B Rev 2008;14:367-75
- Caplan A. Is it sound public policy to let the terminally ill access experimental medical innovations? Am J Bioeth 2007;7:1-3
- Henderson GE, Churchill LR, Davis AM, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med 2007;4:e324
- Kesselheim AS, Robertson CT, Myers JA, et al. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012;367:1119-27
- Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 2012;7:e47559
- Gottlieb S. The FDA wants you for sham surgery. There are better ways to test medical devices than by having patients be placebos who get fake operations. The Wall Street Journal. Available from: http://online.wsj.com/news/articles/SB10001424052702304680904579365414108916816 [Accessed 12 March 2014]
- Miller FG. Sham surgery: an ethical analysis. Sci Eng Ethics 2004;10:157-66